Vergleich

Recombinant Human Tumor necrosis factor receptor superfamily member 11B protein(TNFRSF11B) (Active)

ArtNr CSB-AP002991HU-100
Hersteller Cusabio
Menge 100 ug
Quantity options 1 mg 10 ug 100 ug 250 ug 50 ug 500 ug
Kategorie
Typ Proteins Recombinant
Format Solid
Specific against other
Host Yeast
Konjugat/Tag Fc
Purity >95% as determined by SDS-PAGE and HPLC.
Sequence ETFPPKYLHY DEETSHQLLC DKCPPGTYLK QH CTAKWKTV CAPCPDHYYT DSWHTSDECL YCSP VCKELQ YVKQECNRTH NRVCECKEGR YLEIEF CLKH RSCPPGFGVV QAGTPERNTV CKRCPDGF FS NETSSKAPCR KHTNCSVFGL LLTQKGNATH DNICSGNSES TQKCGIDVTL+ EPKSSDKTHT CPPCPAPEFE GAPSVFLFPP KPKDTLMISR TP EVT
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Osteoclastogenesis inhibitory factor,
Lieferbar
Manufacturer - Category
Cytokine / Tumor Necrosis Factor
Manufacturer - Conjugate / Tag
C-terminal Fc-tagged
Molecular Weight
109.6 kDa
Buffer
0.2um filtered 20 mM PB, pH 6.0, 150 mM NaCl, 0.02 % Tween-80 , lyophilized
General Research Areas
Immunology
Relevance
Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis. {ECO:0000269|PubMed:22664871, ECO:0000269|PubMed:9168977}.
Expression Region
22-201aa
Function
Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.
Subcellular Location
Secreted
Tissue Specificity
Highly expressed in adult lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.
Involvement in disease
Paget disease of bone 5, juvenile-onset (PDB5)
Pathway
Osteoclastdifferentiation
Gene Names
TNFRSF11B, OCIF, OPG
Endotoxin
Less than 1.0 EU/ug as determined by LAL method.
Biological activity
Fully biologically active when compared to standard. The ED50 as determined by neutralizing the stimulation of U937 cells is less than 10 ng/ml, corresponding to a specific activity of ? 1.0 x 105 IU/mg in the presence of 10 ng/mL soluble rHuRANKL (sRANKL).
Manufacturer - Format
Lyophilized powder
Uniprot Entry Name
TR11B_HUMAN
Protein Description
Partial
PubMed ID
9108485; 9492069; 9688283; 14702039; 16421571; 15489334; 9571159; 15340161; 12110935; 9168977; 9603945; 9478964; 11505389; 22664871; 12189164

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen